and NEW YORK, March 11, 2025 (GLOBE NEWSWIRE) -- Arvinas, Inc. (Nasdaq: ARVN) and Pfizer Inc. (NYSE: PFE) today announced positive topline results from the Phase 3 VERITAC-2 clinical trial NEW ...

After hours: March 21 at 7:59:57 PM EDT Loading Chart for PFE ...

After hours: March 14 at 7:59:39 p.m. EDT Loading Chart for PFE ...

Copyright © 2025 MarketWatch, Inc. All rights reserved.

Real time quote data is not available at this time. Nasdaq provides market information before market opens daily from 4:15 A.M. ET to 7:30 A.M. ET on the following day.

Current price $25.82 52-week high $31.54 ...